[1]杨婕琳a,陈文婷b,胡晓利a.结直肠癌组织中硫氧还蛋白-1与硫氧还蛋白互作蛋白的表达及其临床意义[J].现代检验医学杂志,2021,36(06):22-26.[doi:10.3969/j.issn.1671-7414.2021.06.005]
　YANG Jie-lin,CHEN Wen-ting,HU Xiao-li.Expression and Clinical Significance of Thioredoxin-1 and Thioredoxin Interacting Protein in Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(06):22-26.[doi:10.3969/j.issn.1671-7414.2021.06.005]
点击复制

结直肠癌组织中硫氧还蛋白-1与硫氧还蛋白互作蛋白的表达及其临床意义()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年06期
页码:
22-26
栏目:
论　著
出版日期:
2021-12-15

文章信息/Info

Title:
Expression and Clinical Significance of Thioredoxin-1 and Thioredoxin Interacting Protein in Colorectal Cancer
文章编号:
1671-7414（2021）06-022-05
作者:
杨婕琳a; 陈文婷b; 胡晓利a
（河北北方学院附属第一医院a.消化内科 ;b内镜中心, 河北张家口 075000）
Author(s):
YANG Jie-lin;  CHEN Wen-ting;  HU Xiao-li
（a.Department of Gastroenterology;b.Endoscopy Center, the First Affiliated Hospital of Hebei North University, Hebei Zhangjiakou 075000, China）
关键词:
结直肠癌; 硫氧还蛋白-1; 硫氧还蛋白互作蛋白
分类号:
R735.34；R730.43
DOI:
10.3969/j.issn.1671-7414.2021.06.005
文献标志码:
A
摘要:
目的　探讨硫氧还蛋白-1（TRX-1）以及硫氧还蛋白互作蛋白（TXNIP）在结直肠癌组织中的表达及其临床意义。方法　选取2019年1~12月河北北方学院附属第一医院收治的结直肠癌患者72例，另选取同时期在该院接受治疗的结直肠息肉患者40例作为对照组。采用免疫组化法检测手术切除的病理标本中TRX-1和TXNIP的表达情况，分析结直肠癌组织中TRX-1和TXNIP的表达和临床病理特征的关系，分析结直肠癌组织中TRX-1和TXNIP表达的相关性，接受者工作特征曲线（ROC）分析TRX-1和TXNIP对结直肠癌的诊断价值。结果　结直肠癌组织中TRX-1的阳性表达率为66.67%，高于结直肠息肉组织中的25.00%，差异有统计学意义（χ2=17.880，P=0.000），结直肠癌组织中TXNIP的阳性表达率为30.56%，低于结直肠息肉组织中的77.50%，差异有统计学意义（χ2=22.733，P=0.000）。结直肠癌组织中TRX-1的表达与TNM分期、淋巴结转移、肿瘤大小以及分化程度有关（χ2=4.114~4.938，P=0.026~0.043）；结直肠癌组织中TXNIP的表达与TNM分期、淋巴结转移有关（χ2=4.675，5.531，P=0.019，0.031）。结直肠癌组织中TRX-1和TXNIP的表达呈负相关（r=-0.298，P=0.011）。TRX-1和TXNIP对结直肠癌有一定的诊断价值，曲线下面积分别为0.708和0.735，而二者联合可进一步提高诊断价值，曲线下面积为0.792。结论　TRX-1在结直肠癌组织中异常高表达，TXNIP异常低表达，二者的表达水平均与部分临床病理参数有关，且对结直肠癌均有一定的诊断价值。
Abstract:
Objective　To investigate the expression and clinical significance of thioredoxin-1 (TRX-1) and thioredoxin interaction protein (TXNIP) in colorectal cancer. Methods　A total of 72 patients with colorectal cancer who were admitted to the First Affiliated Hospital of Hebei North University from January 2019 to December 2019 were selected, and 40 patients with colorectal polyps who were received treatment in the hospital during the same period were selected as controls group. Immunohistochemical method was used to detect the expression of TRX-1 and TXNIP in surgically resected pathological specimens. The relationship between the expression of TRX-1 and TXNIP in colorectal cancer tissues and clinicopathological characteristics were analyzed, and the correlation between the expression of TRX-1 and TXNIP in colorectal cancer were analyzed. Receiver operating characteristic curve (ROC) was used to analyze the diagnostic value of TRX-1 and TXNIP for colorectal cancer. Results　The positive expression rate of TRX-1 in colorectal cancer tissue was 66.67%, which was higher than 25.00% in colorectal polyp tissue, the difference was statistically significant(χ2=17.880, P=0.000).The positive expression rate of TXNIP in colorectal cancer tissue was 30.56%, which was lower than 77.50% in colorectal polyp tissue, the difference was statistically significant(χ2=22.733, P=0.000). The expression of TRX-1 in colorectal cancer tissue was related to TNM stage, lymph node metastasis, tumor size and degree of differentiation (χ2=4.114~4.938, P=0.026~0.043), and the expression of TXNIP in colorectal cancer tissue was related to TNM stage and lymph node metastasis (χ2=4.675, 5.531, P=0.019, 0.031). The expression of TRX-1 and TXNIP in colorectal cancer tissue was negatively correlated (r=-0.298,P=0.011). TRX-1 and TXNIP had certain diagnostic value for colorectal cancer, and the area under the curve was 0.708 and 0.735, respectively. The combination of the two could further improve the diagnostic value, the area under the curve was 0.792. Conclusion　TRX-1 was abnormally highly expressed in colorectal cancer tissues, and TXNIP was abnormally lowly expressed. The expression levels of both were related to some clinicopathological parameters, and both have certain diagnostic value for colorectal cancer.

参考文献/References:

[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018: GLOBOCAN estimatesof incidence and mortality worldwide for 36 cancers in185 countries[J]. CA-A Cancer Journal for Clinicians,2018, 68(6): 394-424.
[2] 李功娟, 张治洋, 樊阳阳.FEZF1-AS1 在子宫内膜癌中的表达及其与患者临床特征的相关性[J]. 现代检验医学杂志,2021,36(1):77-80.LI Gongjuan,ZHANG Zhiyang,FAN Yangyang. Expressionof FEZF1-AS1 in endometrial carcinomaand its correlation with clinical characteristics ofpatients[J]. Journal of Modern Laboratory Medicine,2021,36(1):77-80.
[3] LEE B W, JEON B S, YOON B. Exogenous recombinanthuman thioredoxin-1 prevents acetaminophen-inducedliver injury by scavenging oxidative stressors,restoring the thioredoxin-1 system and inhibiting receptorinteracting protein-3 overexpression[J]. Journal ofApplied Toxicology , 2018, 38(7): 1008-1017.
[4] 余纪会, 赵文苹, 陈容, 等. 硫氧还蛋白1、触珠蛋白在非小细胞肺癌患者血清中的表达及临床意义[J]. 现代肿瘤医学,2021,29(2):238-242.YU Jihui,ZHAO Wenping,CHEN Rong,et al.Expression and clinical significance of thioredoxin1 and haptoglobin in serum of patients with nonsmallcell lung cancer [J]. Journal of ModernOncology,2021,29(2):238-242.
[5] WEN Chuangyu, WANG Huihui, WU Xiaobin, etal. ROS-mediated inactivation of the PI3K/AKTpathway is involved in the antigastric cancer effectsof thioredoxin reductase-1 inhibitor chaetocin[J]. CellDeath & Disease, 2019, 10(11): 809.
[6] PARK J W, LEE S H, WOO G H, et al. Downregulationof TXNIP leads to high proliferative activityand estrogen-dependent cell growth in breastcancer[J]. Biochemical and Biophysical ResearchCommunications, 2018, 498(3): 566-572.
[7] HORIE K, MIKAMI T, YOSHIDA T, et al. Peroxiredoxin1 expression in active ulcerative colitis mucosaidentified by proteome analysis and involvement of thioredoxinbased on immunohistochemistry[J]. OncologyLetters, 2018, 15(2): 2364-2372.
[8] 张志刚, 倪锋, 党建功, 等.CXC 趋化因子受体4 在肾透明细胞癌中的表达及临床意义[J]. 中华泌尿外科杂志,2017,38(2):88-91.ZHANG Zhigang,NI Feng,DANG Jiangong,et al.Expression of CXC chemokine receptor 4 in clearcell renal cell carcinoma [J]. Chinese Journal ofUrology,2017,38(2):88-91.
[9] 谢鸣, 高磊, 潘铁军.C-MYC 和硫氧还蛋白相互作用蛋白在前列腺癌组织的表达及临床意义[J]. 中华实验外科杂志,2019,36(2):340-342.XIE Ming,GAO Lei,PAN Tiejun. Expression andsignificance of C-MYC and thioredoxin-interactingprotein in prostate cancer [J]. Chinese Journal ofExperimental Surgery,2019,36(2):340-342.
[10] TESTA U, PELOSI E, CASTELLI G. Colorectal cancer:genetic abnormalities, tumor progression, tumorheterogeneity, clonal evolution and tumor-initiatingcells[J]. Medical Sciences (Basel, Switzerland), 2018,6(2): 31.
[11] SIEGEL R L, MILLER K D, FEDEWA S A, et al.Colorectal cancer statistics, 2017[J]. CA-A CancerJournal for Clinicians, 2017, 67(3): 177-193.
[12] HALILOVIC E, RASIC I, SOFIC A, et al. The importanceof determining preoperative serum concentrationof carbohydrate antigen 19-9 and carcinoembryonicantigen in assessing the progression of colorectal cancer[J]. Medical Archives (Sarajevo, Bosnia and Herzegovina),2020, 74(5): 346-349.
[13] 杨荟敏, 邢素倩, 白晓旭, 等. 硫氧还蛋白-1 减弱脂连蛋白对小鼠移植性肝癌生长的抑制作用[J]. 中国生物化学与分子生物学报,2017,33(9):900-907.YANG Huimin,XING Suqian,BAI Xiaoxu,et al.Thioredoxin 1 alleviates the inhibitory effect ofAPN on mouse grafted hepatocellular carcinoma[J]. Chinese Journal of Biochemistry and MolecularBiology,2017,33(9):900-907.
[14] 潘涛. 远端胃癌根治术术后复发转移与硫氧化还原蛋白-1 表达的关系[J]. 医学临床研究,2018,35(2):251-253.PAN Tao. Relationship between recurrence andmetastasis and expression of thioredoxin -1 after radicalresection of distal gastric cancer [J]. Journal of ClinicalResearch,2018,35(2):251-253.
[15] ZUO Zhigui, ZHANG Peili, LIN Feiyan, et al. Interplaybetween Trx-1 and S100P promotes colorectal cancercell epithelial-mesenchymal transition by up-regulatingS100A4 through AKT activation[J]. Journal of cellularand molecular medicine, 2018, 22(4): 2430-2441.
[16] WANG Wenqi, FANG Daoquan, ZHANG Hao, etal. Sodium butyrate selectively kills cancer cells andinhibits migration in colorectal cancer by targeting thioredoxin-1.[J]. Onco Targets and Therapy, 2020, 13 :4691-4704.
[17] WANG Fule, LIN Feiyan, ZHANG Peili, et al.Thioredoxin-1 inhibitor, 1-methylpropyl 2-imidazolyldisulfide, inhibits the growth, migration and invasion ofcolorectal cancer cell lines[J]. Oncology Reports, 2015,33(2): 967-973.
[18] CHO M J, YOON S J, KIM W, et al. Oxidative stressmediatedTXNIP loss causes RPE dysfunction[J].Experimental & Molecular Medicine, 2019, 51(10): 1-13.
[19] LIN Feiyan, ZHANG Peili, ZUO Zhigui, et al.Thioredoxin-1 promotes colorectal cancer invasion andmetastasis through crosstalk with S100P[J]. CancerLetters, 2017, 401: 1-10.
[20] 莫与琳, 杨亚军, 崔燎.TXNIP 介导的氧化应激在疾病中的作用机制[J]．中国药理学通报,2018,34(1):16-19.MO Yulin,YANG Yajun,CUI Liao. Action andmechanism of oxidative stress mediated by TXNIPin diseases [J]. Chinese Pharmacological Bulletin,2018,34(1):16-19.
[21] KIM Y, KIM Y S, KIM M, et al. Thioredoxin-interactingprotein (TXNIP) mediates thioredoxin-dependentantioxidant mechanism in endometrial cancer cellstreated with 1α,25-dihydroxyvitamin D(3)[J]. AnticancerResearch, 2019, 39(9): 4795-4803.

相似文献/References:

[1]陈建国.结直肠癌患者FOLFOX化疗与GSTP1,XRCC1基因多态性的研究[J].现代检验医学杂志,2016,31(05):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
　CHEN Jian-guo.Relationship between FOLFOX Chemotherapy of Colorectal Cancer Patients and GSTP1,XRCC1 Gene Polymorphism[J].Journal of Modern Laboratory Medicine,2016,31(06):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
[2]周秋媛,王红莉,李虹,等.NRP-1和NRP-2在结直肠癌组织中的表达水平及临床意义[J].现代检验医学杂志,2016,31(06):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
　ZHOU Qiu-yuan,WANG Hong-li,LI Hong,et al.Serum NRP-1 and NRP-2 Expression in Colorectal Cancer Patients and Its Relationship with Clinical Pathology[J].Journal of Modern Laboratory Medicine,2016,31(06):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
[3]史 敏,郭晓波,李思远,等.结直肠癌患者组织中K-ras和BRAF基因突变与不同病理特征的相关性分析[J].现代检验医学杂志,2018,33(03):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
　SHI Min,GUO Xiao-bo,LI Si-yuan,et al.Correlation of K-ras and BRAF Mutations with Pathological Features in Patients with Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(06):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
[4]井丰军,倪勇.结直肠癌患者外周血NLR与RDW的变化及临床意义[J].现代检验医学杂志,2018,33(03):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
　JING Feng-jun,NI Yong.Change and Significance of Neutrophil/Lymphocyte Ratio and Red Blood Cell Distribution Width of Peripheral Blood in the Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(06):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
[5]滕祥云,王新梦,刘　维,等.中国汉族结直肠癌患者 UGT1A1*28基因多态性分析[J].现代检验医学杂志,2019,34(06):20.[doi:10.3969 ／ j.issn.1671-7414.2019.06.005]
　TENG Xiang-yun,WANG Xin-meng,LIU Wei,et al.Polymorphism of UGT1A1*28 Gene in Han Patients with Colorectal Cancer in China[J].Journal of Modern Laboratory Medicine,2019,34(06):20.[doi:10.3969 ／ j.issn.1671-7414.2019.06.005]
[6]陈 培,邓钦木,李丹丹.血浆Septin9 甲基化检测在结直肠癌中的诊断价值[J].现代检验医学杂志,2020,35(04):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
　CHEN Pei,DENG Qin-mu,LI Dan-dan.Diagnostic Value of Plasma Septin9 Methylation in Screening of Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2020,35(06):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
[7]马胜辉,崔雪琴,李建华,等.结直肠癌组织miR-485-5p，miR-1207-3p和miR-590-3p水平表达与临床病理特征及生存的相关性研究[J].现代检验医学杂志,2022,37(03):16.[doi:10.3969/j.issn.1671-7414.2022.03.004]
　MA Sheng-hui,CUI Xue-qin,LI Jian-hua,et al.Correlation of miR-485-5p, miR-1207-3p, miR-590-3p Level Expression and Clinicopathologic Characteristics and Survival in Colorectal Cancer Tissue[J].Journal of Modern Laboratory Medicine,2022,37(06):16.[doi:10.3969/j.issn.1671-7414.2022.03.004]
[8]胡道军,史文杰,孙 敏.LncRNA NEAT1/miR-23b-3p/KLF3 轴调控结直肠癌细胞的生物学功能研究[J].现代检验医学杂志,2022,37(04):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
　HU Dao-jun,SHI Wen-jie,SUN Min.LncRNA NEAT1/miR-23b-3p/ KLF3 Axis Regulates the Biological Function of Colorectal Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(06):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
[9]冯 芬.结直肠癌组织中USP11 和PPP1CA 表达水平与临床病理的相关性研究[J].现代检验医学杂志,2022,37(04):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]
　FENG Fen.Correlation between USP11 and PPP1CA Expression Levels and Clinicopathology in Colorectal Cancer Tissues[J].Journal of Modern Laboratory Medicine,2022,37(06):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]
[10]郑光明,孙建华,宋秋月.结直肠癌组织中锌指蛋白139（ZNF139）的表达及临床意义研究[J].现代检验医学杂志,2022,37(04):107.[doi:10.3969/j.issn.1671-7414.2022.04.021]
　ZHENG Guang-ming,SUN Jian-hua,SONG Qiu-yue.Expression and Clinical Significance of Zinc Finger Protein 139 (ZNF139) in Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2022,37(06):107.[doi:10.3969/j.issn.1671-7414.2022.04.021]

备注/Memo

备注/Memo:
基金课题：2019河北省卫健委青年科技课题（20190874）。作者简介：杨婕琳(1984-)，女，硕士研究生，主治医师，研究方向：消化病学，E-mail:yyj11884@163.com。
更新日期/Last Update: 1900-01-01